Euclises Pharmaceuticals' Series A - II Round

Euclises Pharmaceuticals raised a round of funding on April 07, 2015.

Euclises Pharmaceuticals (Euclises) is a drug discovery and development company focused on novel cyclooxygenase-2 (COX-2) inhibitors for use in the oncology setting. Euclises has developed a portfolio…

Articles about Euclises Pharmaceuticals' Series A - II Round: